Stockscreener 앱 받기
1,213.91
1.86%
22.17
시간 외 거래:
1212.48
-1.43
-0.12%
Lilly Eli Co 주식(LLY)의 최신 뉴스
Charles River Laboratories International (CRL) On Lilly TuneLab Deal And The Valuation Debate - simplywall.st
Eli Lilly (LLY) Faces China Trial Probe While Handing Verzenios Rights To Innovent - simplywall.st
Is Eli Lilly (LLY) One of Billionaire Cliff Asness’ Best Healthcare Stock Picks ? - Insider Monkey
Why Is Eli Lilly (NYSE:LLY) Obesity Pill In Focus? - Kalkine Media
Medicare Expands Access to GLP-1 Drugs, Boosting Eli Lilly (LLY) and Novo Nordisk (NVO) - GuruFocus
Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China - Benzinga
$100 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today - Benzinga
Eli Lilly & Co. highlights its role in innovative diabetes care - AD HOC NEWS
Mounjaro from Eli Lilly & Co.dual-action diabetes drug expands US reach - AD HOC NEWS
Eli Lilly Hits Highs on GLP-1 Medicare Inclusion, Huge Results - FXEmpire
Eli Lilly (LLY) and Novo Nordisk (NVO) to Benefit from New Medic - GuruFocus
Medicare opens access to GLP-1 weight-loss drugs (LLY:NYSE) - Seeking Alpha
$Eli Lilly and Co (LLY.US)$ break and retest. 1300+ might be understatement from me. - Moomoo
Hybio challenges Eli Lilly with FDA bid for tirzepatide generic - China Daily
Hanmi Receives $75 Million Upfront from Eli Lilly - Businesskorea
Korea Lilly names Komatsu Seiya CEO to accelerate innovation pushCHOSUNBIZ - Chosunbiz
Innovent and Lilly Expand China Oncology Partnership with Verzenios Commercialisation Agreement - BioPharma APAC
Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals - AOL.com
Pennsylvania invests millions to train workers for Eli Lilly facility opening in 2031 - PennLive.com
Lilly taps Abbisko for $1.9B discovery deal - BioWorld News
Why is Eli Lilly stock sliding today? - Investing.com
U.S. Stocks Move | Eli Lilly and Co (LLY.US) Drops Over 2% as Weight-Loss Drug Included in Medicare Reimbursement for the First Time - 富途牛牛
Can Eli Lilly's New Drugs Fuel Growth Beyond Its GLP-1 Blockbusters? - Yahoo Finance
Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness - Benzinga
Eli Lilly Transfers Commercialization Rights for Breast Cancer Drug in ChinaU.S. News - U.S. News - Money
Eli Lilly transfers commercialization rights for breast cancer drug in China - Reuters
Eli Lilly Upgraded, Carvana Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Eli Lilly (LLY) Stock Hits $1,230 in June 2026 — Strong Sales of Mounjaro & Zepbound Drive Gains - FXLeaders
Eli Lilly And Company (NYSE:LLY) Advances Metabolic Medicine Frontier - Kalkine Media
The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordisk - STAT
Ranking Wall Street's Trillion-Dollar Stocks From Most to Least Attractive, Based on Future Cash Flow - The Motley Fool
5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX - The Motley Fool
Eli Lilly Is Dominating the GLP-1 Market: Here's What a $5,000 Investment Could Look Like in 5 Years - The Motley Fool
Lilly hands Innovent China rights to breast cancer drug Verzenios - Stock Titan
LLYLilly(Eli) & Co Latest SEC Filings - Finviz
Eli Lilly (LLY) Joins FDA PreCheck Pilot Program to Enhance Drug Manufacturing - GuruFocus
Eli Lilly (LLY) Joins FDA Pilot Program to Strengthen U.S. Drug Manufacturing - GuruFocus
Lilly, Regeneron selected for US program to review new manufacturing plants faster - Reuters
Eli Lilly (LLY) Joins FDA PreCheck Pilot Program for Manufacturi - GuruFocus
Lilly, Regeneron selected for US program to review new manufacturing facilities faster, CNBC reports - Yahoo
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities - CNBC
How Is Eli Lilly (NYSE:LLY) Positioned As Healthcare Hits Record Highs? - Kalkine Media
Lilly partners with P2U on private Mounjaro dispensing service - Pharmacy Magazine
The Investment Case for Eli Lilly and Co (LLY): How Financial Gr - GuruFocus
U.S. Stock Market Update | Eli Lilly and Co (LLY.US) hits a new all-time high, up over 14% year-to-date - 富途牛牛
Here's Why Shares of Eli Lilly Hit an All-Time High on Friday - The Globe and Mail
Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,350 - 富途牛牛
Lilly (LLY) Moves 7.1% Higher: Will This Strength Last? - Yahoo Finance
Lilly launches home delivery service for privately prescribed medicines - The Pharmacist News
ZAWYA: Lilly and Department of Health – Abu Dhabi aim to advance management of obesity and alzheimer’s disease - TradingView
Eli Lilly and Company (LLY) Up More Than 6% Over the Past Month, Can it Move Higher? - Insider Monkey
Inside Lilly's biotech startup factory - The Korea Herald
Is Eli Lilly and Company (LLY) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds? - Insider Monkey
Nesbitt to roll out weight loss drugs with support from Mounjaro maker Eli Lilly - Belfast News Letter
Lilly launches “The Memory Radio Station” across Europe, inviting the public to visually reconstruct fading memories through GenAI - Eli Lilly and Company
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management - investor.lilly.com
Eli Lilly and Co. | Pharmaceuticals, Biomedical Research, & Company - Encyclopedia Britannica
List of 38 Acquisitions by Lilly (Jun 2026) - Tracxn
Eli Lilly (LLY) and BioArctic AB Enter into Research and Collaboration Agreement - Insider Monkey
Here’s What the Street Thinks About Eli Lilly and Company (LLY) - Insider Monkey
Eli Lilly Stock (LLY) Opinions on Analyst Notes Amid Obesity Drug Shifts - Quiver Quantitative
Eli Lilly & Co Soars on Drug Pipeline Breakthroughs - TipRanks
3.57%
자본화:
|
볼륨(24시간):